| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8444491 | European Journal of Cancer | 2013 | 11 Pages |
Abstract
Our study demonstrates that ADAM12 expression not only favours tumour growth but also associates enhanced osteolysis with a significant reduction in animal survival, suggesting that ADAM12 could be a new therapeutic target in osteosarcoma.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Steven Georges, Julie Chesneau, Soizic Hervouet, Julien Taurelle, François Gouin, Françoise Redini, Marc Padrines, Dominique Heymann, Yannick Fortun, Franck Verrecchia,